Hopper seeks backers for IPO candidate Radiopharm
MELBOURNE: The biotech sector is going nuclear. Industry doyen Paul Hopper is back with his… read more
ResMed gains but supply squeeze bites ability to grow
MELBOURNE: ResMed boss Mick Farrell is tipping as much as $US350 million ($470 million) in… read more
16 new senior healthcare executives sought for key roles
MELBOURNE: Sixteen senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
ResMed result is no dream for investors say analysts
MELBOURNE: ResMed shares have fallen by as much as 3.3 per cent throughout Friday despite… read more
